Drug Type Virus-like Drug Conjugates (VDCs) |
Synonyms MVR V002, MVRV002 |
Target |
Action inhibitors |
Mechanism Viral proteins inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Influenza, Human | Preclinical | South Korea | 08 Aug 2023 |





